Search clinical trials for: Continuous Subcutaneous Insulin Infusion - CSII

Total 18191 results

Hospital Clinic of Barcelona

Unknown

Study to Evaluate the Pharmacokinetics of Vitamin D (Cholecalciferol) in Patients Undergoing Obesity Surgery in a Deficit Situation and After Standardization (PK-VIT-D)

Obesity | Gastrectomy | Gastric Bypass

Spain
Peking University Third Hospital

Not yet recruiting

CSII Versus MDI in Pregnant Women With Type 2 Diabetes

Type 2 Diabetes | Pregnancy in Diabetic

China
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes (DSS-2)

Diabetes Mellitus, Type 1

United States
University Hospital, Montpellier
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Recruiting

Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia (DCLP2)

Type 1 Diabetes Mellitus With Hypoglycemia

France
Medical University of Graz

Recruiting

Inflammatory Response to CSII Catheters in a Tummy Tuck Model (IRCATT)

Diabetes Mellitus

Austria
Sun Yat-sen University
Guangdong Provincial Hospital of Traditional Chinese Medicine; The Third Affiliated... and other collaborators

Recruiting

Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Marc Breton
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery (Rocket-BPS)

Type 1 Diabetes

United States
Nemours Children's Clinic

Completed

Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)

Diabetes Mellitus, Insulin-Dependent

United States
Mannkind Corporation

Completed

Afrezza With Basal Combination (ABC)

Type 1 Diabetes

United States
Capillary Biomedical, Inc.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Integrated... and other collaborators

Completed

Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients ("PEXIS")

Diabetes Mellitus, Type 1 | Type 1 Diabetes

United States
Kinderkrankenhaus auf der Bult

Completed

Study on the Use of the Insulin Pump Tandem X:2 With Control IQ Algorithm - Update (UNIQUE)

Type 1 Diabetes | Insulin Therapy

Germany
Sheffield Teaching Hospitals NHS Foundation Trust
King's College Hospital NHS Trust; Cambridge University Hospitals NHS Foundation... and other collaborators

Completed

The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial (REPOSE)

Type 1 Diabetes

United Kingdom
Medtronic Diabetes
Medtronic Poland Spółka z ograniczoną odpowiedzialnością

Completed

Orchestra Pregnancy Observational Study in Poland

Pregnancy | Type 1 Diabetes Mellitus

Poland
Castilla-La Mancha Health Service
Universidad de Córdoba; University of Castilla-La Mancha

Completed

Continuous Subcutaneous Insulin Infusion Versus Multiple Dose Insulin Injections in Routine Clinical Practice (real-ECIMI)

Type 1 Diabetes Mellitus

Spain
J.H. DeVries
Rijnstate Hospital; Inreda Diabetic B.V.

Completed

Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format, (APPEL5)

Diabetes Mellitus, Type 1

Netherlands
Nanjing First Hospital, Nanjing Medical University

Unknown

Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus
Beijing Hospital

Unknown

Comparing the Efficacy and Safety Between Short-term Continuous Subcutaneous Beinaglutide Injection and Continuous Subcutaneous Insulin Infusion (CSII) for Newly Diagnosed Type 2 Diabetes

Type 2 Diabetic Patients

China
Halozyme Therapeutics

Completed

Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase

Type 1 Diabetes Mellitus

United States
LMC Diabetes & Endocrinology Ltd.

Unknown

Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered (FIT Untethered)

Type 1 Diabetes Mellitus

Canada
Halozyme Therapeutics

Completed

A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20) (HALO-117-406)

Type 1 Diabetes Mellitus

United States
The First Affiliated Hospital of Xiamen University

Unknown

Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes

T2DM

China
Sun Yat-sen University

Suspended

Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University

Completed

Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes

Diabetes Mellitus, Type 2

China
Fundación Pública Andaluza para la Investigación...
Roche Pharma AG; Andaluz Health Service; Ministerio de Economía y Competitividad...

Completed

Telemedicine Program in Type 1 Diabetes and CSII

Diabetes Mellitus, Type 1
King's College London
University Hospital, Caen; University of Leicester

Completed

Individual Patient Data Meta-analysis of CSII vs. MDI in Type 2 Diabetes

Diabetes Mellitus, Type 2
University Hospital, Caen
Eli Lilly and Company

Unknown

Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes (EXEPUMP)

Type 2 Diabetes

France
CeQur Corporation

Completed

A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
CeQur Corporation

Terminated

A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
Liverpool John Moores University
Liverpool University Hospitals NHS Foundation Trust

Completed

CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Cross-Sectional Study

Type 1 Diabetes

United Kingdom
Liverpool John Moores University
Liverpool University Hospitals NHS Foundation Trust

Completed

CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Longitudinal Study

Type 1 Diabetes

United Kingdom
Endocrinology Research Centre, Moscow

Completed

Education Effectiveness for Type 1 Diabetes Mellitus on Insulin Pump Therapy (EASEDIAP)

Diabetes Mellitus, Type 1
University of Cambridge
Medical University of Graz; Profil Institut für Stoffwechselforschung GmbH

Completed

Closing the Loop in Adults With Sub-optimally Controlled Type 1 Diabetes Under Free Living Conditions (AP@home04)

Type 1 Diabetes

United Kingdom, Austria, Germany
Jothydev's Diabetes and Research Centre

Completed

Exploratory CSII Trial on Erectile Dysfunction in T2DM Patients (ECSIITED)

Diabetes Mellitus, Type 2 | Erectile Dysfunction

India
Halozyme Therapeutics

Completed

Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)

Type 1 Diabetes Mellitus

United States
Abbott Diabetes Care

Completed

Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System

Type 1 Diabetes | Type 2 Diabetes

United States
Eli Lilly and Company

Completed

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

Type 2 Diabetes Mellitus

United States
Shanghai Jiao Tong University School of Medicine

Unknown

Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy (CAMACS)

Type 2 Diabetes

China
Fundación para la Investigación del Hospital Clínico...
European Union; Ministerio de Ciencia e Innovación, Spain

Completed

New Strategies for Postprandial Glycemic Control Using Insulin Pump Therapy

Type 1 Diabetes

Spain
Institute of Mother and Child, Warsaw, Poland

Unknown

The ADHERENCE Index - the Indicator of Effective Coping With the Requirements of the Disease of Children and Adolescents With Type 1 Diabetes (ADHERENCE)

Type 1 Diabetes

Poland
Buckinghamshire Healthcare NHS Trust
Animas Corporation

Completed

Managing Insulin Pumps for Exercise - Study 1

Type 1 Diabetes Mellitus

United Kingdom
Sanofi

Completed

Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus (PUMP)

Diabetes Mellitus, Type 1

France, Australia, Spain, Sweden, United States, Austria, Hungary, Israel, Italy, United Kingdom, Korea, Republic of, Netherlands
DexCom, Inc.

Completed

Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) Therapy

Type 1 Diabetes Mellitus

United States
University of Aarhus

Completed

Pharmacokinetics of IAsp Following CSII in Patients With T1DM

Type 1 Diabetes Mellitus

Denmark
Medical Research Foundation, The Netherlands
Medtronic

Completed

Study to Compare Intraperitoneal Insulin to Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Netherlands
McGill University
Canadian Diabetes Association

Completed

Impact of Optimized Titration and Delivery of Bedtime Insulin on Prevention of Nocturnal Hypoglycemia

Type 1 Diabetes Mellitus

Canada
Erasmus Medical Center
Ministry of Health

Completed

Comparison Between Insulin Pump Treatment and Multiple Daily Insulin Injections in Diabetic Type 1 Children

Diabetes Mellitus, Type 1 | Child

Netherlands
Newcastle University
Sanofi; Medtronic; Newcastle-upon-Tyne Hospitals NHS Trust; Newcastle Primary Care...

Completed

Prevention of Severe Hypoglycemia in Type 1 Diabetes

Type 1 Diabetes Mellitus

United Kingdom
Mayo Clinic

Not yet recruiting

Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus

Type 1 Diabetes

United States
First Affiliated Hospital of Guangxi Medical University

Recruiting

Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM

Type2diabetes

China
VitalAire

Not yet recruiting

Impact of the Use of a Closed-loop Insulin Therapy on the Burden of the Diabetes and the Quality of Life (IMPLIQUE)

Quality of Life | Burden, Dependency

Search clinical trials for: Continuous Subcutaneous Insulin Infusion - CSII

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations